Ratios of pharmacological treatment for secondary prevention per
region
Figure 3 shows the
pharmacological treatment for secondary prevention recommended upon
hospital discharge per region. The recommended ratio of the drugs for
both types of infarction and in all three regions was high. The rates of
RAAS inhibitor treatment for STEMI were significantly lower in the ER
than in the CR (78.7% vs. 83.6%), but the ratios for beta-blocker
therapy were lower in the WR than in the other two regions for both
types of infarction.